Ex-CTI BioPharma CEO seeks startup funds as yacht lawsuit dismissed


Dr. James Bianco has faced multiple debt collection and class action lawsuits since stepping down as CEO of CTI BioPharma in late 2016.

Previous Bryn Mawr Trust on executive hiring spree
Next Verity issues layoff notice for Silicon Valley health clinic workers